Insight Molecular Diagnostics is back in focus after analysts updated their price target, with some now pointing to US$12 alongside a refreshed fair value estimate of US$8.33, previously US$7.00. That ...
This is an audio transcript of The Economics Show podcast episode: ‘Could common debt make the EU stronger? With Carlos ...
Key considerations for health plan sponsors in covering family-building benefits (including in vitro fertilization (IVF)) ...
IDEXX Laboratories, Inc. (IDXX) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 9:15 AM ESTCompany ParticipantsJay Mazelsky ...
FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise medication decisions, today announced momentum in pilot adoption of its new Model ...
Know true value your lab offers by accurately assessing fee-for-service testing margins before selling or restructuring health system labs.
Treatment Phase for Lead Clinical Candidate PH-762 Dose Escalation Trial is Complete with Favorable Safety, Tolerability and ...
Six years in, the Sustainable Markets Initiative is switching from industry working groups to cross-industry collaboration.
New research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) to identify ...
ARK Invest acquired $19.4M in CoreWeave and $23.2M in Kratos Defense on Feb 27 while selling Teradyne and Rocket Lab. Full ...
Our most recent round of baby formula tests detected contaminants at potentially concerning levels in 26 of the 49 baby ...
Treatment Phase for Lead Clinical Candidate PH-762 Dose Escalation Trial is Complete with Favorable Safety, Tolerability and Pathology Data 2025 Financings and Warrant Exercises Strengthen Balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results